Publicacións (24) Publicacións nas que participase algún/ha investigador/a

filter_list Immunology

2024

  1. Signature Proteins in Small Extracellular Vesicles of Granulocytes and CD4+ T-Cell Subpopulations Identified by Comparative Proteomic Analysis

    International Journal of Molecular Sciences, Vol. 25, Núm. 19

  2. Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 656-666

  3. Triple inhaled therapy in asthma: Beliefs, behaviours and doubts

    Pulmonary Pharmacology and Therapeutics, Vol. 87

2023

  1. Airway hyperresponsiveness reflects corticosteroid-sensitive mast cell involvement across asthma phenotypes

    Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 1, pp. 107-116.e4

  2. Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study): A Double-Blind Randomized Controlled Trial

    American journal of respiratory and critical care medicine, Vol. 207, Núm. 9, pp. 1161-1170

  3. Alpha-1 antitrypsin deficiency and Pi*S and Pi*Z SERPINA1 variants are associated with asthma exacerbations

    Pulmonology

  4. Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231

  5. Real-Life Effectiveness of Benralizumab, Mepolizumab and Omalizumab in Severe Allergic Asthma Associated with Nasal Polyps

    Clinical Reviews in Allergy and Immunology, Vol. 64, Núm. 2, pp. 179-192

2022

  1. Association of rhinitis with asthma prevalence and severity

    Scientific Reports, Vol. 12, Núm. 1

  2. Multi-ancestry genome-wide association study of asthma exacerbations

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, Vol. 33, Núm. 6, pp. e13802

  3. Proteomic analysis of food allergens

    Food Proteomics: Technological Advances, Current Applications and Future Perspectives (Elsevier), pp. 225-300

  4. Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients

    Archivum Immunologiae et Therapiae Experimentalis, Vol. 70, Núm. 1

2021

  1. Cost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in Spain

    Journal of Medical Economics, Vol. 24, Núm. 1, pp. 874-882

  2. Distinctive cd26 expression on cd4 t-cell subsets

    Biomolecules, Vol. 11, Núm. 10

  3. Igf1r as a potential pharmacological target in allergic asthma

    Biomedicines, Vol. 9, Núm. 8

  4. Immunology and immunotherapy in CRC

    Foundations of Colorectal Cancer (Elsevier), pp. 435-453

2020

  1. iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and nonallergic asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 12, pp. 3171-3183

2019

  1. Expansion of different subpopulations of CD26 −/low T cells in allergic and non-allergic asthmatics

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Expansion of a CD26low effector th subset and reduction in circulating levels of sCD26 in stable allergic asthma in adults

    Journal of Investigational Allergology and Clinical Immunology, Vol. 28, Núm. 2, pp. 113-125

  2. The CD14 (-159 C/T) SNP is associated with sCD14 levels and allergic asthma, but not with CD14 expression on monocytes

    Scientific Reports, Vol. 8, Núm. 1